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Abstract
The overall aim of this scoping review of the literature is twofold: (1) to provide an overview of all instruments that have 
been used to assess health-related quality of life (HRQoL) after solid organ transplantation and (2) to provide a list of health 
items they include to support future studies on the development of a new-generation HRQoL instrument. All studies that 
administered any form of HRQoL instrument to post-transplant solid organ recipients were identified in a comprehensive 
search of PubMed (MEDLINE), Embase, and Web of Science, with a cut-off date of May 2018. The search used various 
combinations of the following keywords: lung, heart, liver, kidney, or pancreas transplantation; quality of life; well-being; 
patient-reported outcome; instrument; questionnaire; and health survey. In total, 8013 distinct publications were identified 
and 1218 of these were selected for review. Among the instruments applied, 53 measured generic, 51 organ-specific, 271 
domain-specific, and 43 transplant-specific HRQoL. A total of 78 distinct health items grouped into 16 sub-domains were 
identified and depicted graphically. The majority of publications did not report a logical rationale for the choice of specific 
HRQoL instrument. The most commonly used types of instruments were generic health instruments, followed by domain-
specific instruments. Despite the availability of transplant-specific instruments, few studies applied these types of instruments. 
Based on the 78 items, further research is planned to develop a patient-centered, transplant-specific HRQoL instrument that 
is concise, easy to apply (mobile application), and specifically related to the health issues of solid organ recipients.
Key Points for Decision Makers 
This scoping review provides an overview of all instru-
ments that have been used to assess health-related qual-
ity of life (HRQoL) after transplantation. This overview 
will be useful in the process of instrument selection in 
future studies.
Generic instruments are the most frequently applied 
HRQoL instruments in solid organ transplantation stud-
ies. Despite the availability of transplant-specific instru-
ments, only a few studies have applied these types of 
instruments to measure HRQoL in transplant patients.
There is a need to develop a preference-based, trans-
plant-specific HRQoL instrument. Such an instrument 
should be easy to apply, and its content should target the 
health issues of solid organ recipients from the patient 
perspective.
Electronic supplementary material The online version of this 
article (https ://doi.org/10.1007/s4027 1-018-0335-3) contains 
supplementary material, which is available to authorized users.
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1 Introduction
With respect to the considerable improvements in clinical 
outcomes in the field of solid organ transplantation (i.e., 
lung, heart, liver, kidney, and pancreas), there is grow-
ing awareness of post-transplant perceived health status 
or health-related quality of life (HRQoL) [1–4]. Today, 
the main objectives of organ transplantation include exten-
sion of survival, decrease in the level of disability, and 
improvement of HRQoL [5].
HRQoL is a multi-dimensional concept that refers to the 
overall impact of health aspects on an individual’s quality 
of life [6, 7]. More specifically, HRQoL embraces physi-
cal symptoms, functional status, psychological states, and 
social relationships. Together these constitute the domains 
of the World Health Organization’s (WHO) definition of 
health [7–10].
Before transplantation, a patient’s HRQoL is signifi-
cantly reduced due to clinical dysfunction of the failing 
organ and psychosocial distress. Shortly after transplan-
tation, a significant increase in HRQoL is observed [11, 
12]. However, life-long, immunosuppressive regimens are 
necessary to prevent organ rejection, and chronic expo-
sure to these medications is associated with complications 
that adversely affect the HRQoL of solid organ transplant 
recipients [13–15]. Previous studies have emphasized that 
a considerable proportion of patients are more concerned 
about HRQoL than about survival [16, 17].
Numerous instruments are available to measure HRQoL 
of transplant patients. Here, “instrument” refers to any 
form of self-report questionnaire and rating scale that is 
used to measure any aspect of an individual’s HRQoL. 
Most reviews of post-transplant HRQoL studies have 
focused on frequently used instruments in only one or two 
organ types, so they may have omitted some less well-
known instruments. Recent systematic reviews of the lit-
erature on HRQoL in lung, liver, kidney, and pancreas 
transplant patients have revealed that the most common 
instruments are the 36-Item Short Form Survey (SF-36) 
and the EuroQol—5 Dimensions (EQ-5D) [4, 18–22]. 
These two instruments have proven to be beneficial in 
measuring the health status and outcomes associated with 
healthcare interventions [23]. However, these are generic 
instruments and thus do not contain health items that are 
specifically relevant to post-transplant patients.
With increased attention being paid to the concept of 
HRQoL among transplant patients, targeted measurement 
of HRQoL is becoming more important. An appropriate 
transplant-specific instrument should cover the full spec-
trum of HRQoL and assess both general and transplant-
specific health issues of patients. Additionally, although 
many existing HRQoL instruments measure the intensity 
or frequency of complaints, they lack the ability to meas-
ure the impact of these complaints on the health status 
experienced by patients [24–26]. To measure the latter, 
specially designed instruments are necessary, derived from 
methodologies that include the preferences of patients. 
Special judgmental tasks (e.g., ordering a set of health 
states or paired comparisons between different health state 
descriptions) are a central element in such instruments [7, 
27]. Embedding patients’ preferences into health-outcome 
instruments is becoming increasingly important, due to the 
increasing attention being paid to patient-centered health-
care [28–31].
Some generic preference-based HRQoL instruments, for 
example, the Health Utilities Index-3 (HUI-3) and EQ-5D, 
are available. However, their content is not focused on the 
specific health issues of transplant patients, and the selection 
of the health items in these instruments is mainly based on 
expert opinion [24, 31]. Moreover, the determination of the 
importance of the various health items, which consist of a 
value-judgment task, is based on a representative community 
sample [32–35]. Recently, a novel preference-based method 
has been introduced, which makes it possible for patients 
themselves to make the value judgements [34, 36]. There-
fore, we see a need for a preference-based, patient-centered, 
transplant-specific HRQoL instrument.
The first step in developing a patient-centered HRQoL 
instrument for transplant patients is to extract relevant health 
items from existing instruments [37, 38]. Therefore, we con-
ducted a scoping review of the literature to provide an over-
view of all instruments that have been used to assess HRQoL 
after transplantation in major solid organ recipients. Our aim 
was to find all studies that evaluated any aspects of HRQoL 
in post-transplant patients and subsequently to identify all 
instruments and health items used. This study is not directed 
to the psychometric properties of the instruments or con-
cerned with recommending the best instruments available.
2  Methods
2.1  Study Design and Literature Search Strategy
A scoping literature review was conducted to extract all 
HRQoL instruments that had been administered to major 
solid organ transplant recipients. This was not a systematic 
review, but rather aimed at acquiring adequate information 
about existing HRQoL instruments to establish a basis for 
formulating relevant items. To identify relevant studies, the 
three major electronic databases, namely PubMed (MED-
LINE), Embase, and Web of Science, were searched to May 
2018. To ensure we included all self-reported instruments 
that have thus far been applied, different combinations of 
broad keywords and medical subject heading (MeSH) terms 
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were formulated to cover three domains: (1) solid organ 
transplantation, i.e., lung, heart, liver, kidney, or pancreas 
transplantation; (2) quality of life, i.e., quality of life itself, 
well-being, or patient-reported outcome; and (3) instru-
ments, i.e., questionnaire or health survey. The search strat-
egy was discussed with four experts on epidemiological and 
transplant studies (PK, EB, KV, and SB) to finalize the list 
of keywords (Fig. 1).
2.2  Identification of Relevant Literature 
and Eligibility Criteria
We included all original publications in English if they 
met the following criteria: (1) human studies in which the 
participants had been transplanted with at least one of the 
five major solid organs and were ≥ 18 years old at the time 
of the study; (2) studies that evaluated symptoms, physical 
functioning, psychological distress, or social relationships in 
terms of health outcomes; and (3) studies that used any form 
of HRQoL instrument.
The finalized list of keywords was then used to select 
potentially eligible articles for title and abstract review. 
Because our aim was to include all studies that assessed 
HRQoL in the post-transplant population, we only 
excluded publications that clearly did not meet the inclu-
sion criteria, and retained all other references for full 
text review. If there was any doubt, the full article was 
retrieved and the methods section was read to check selec-
tion criteria. Studies were excluded if they were restricted 
to donors, organ transplant candidates, pediatric transplant 
recipients, and family or relatives of the patient. Case stud-
ies, editorials, letters to the editor, meta-analyses, system-
atic reviews, and books were also all excluded from the 
review. Subsequently, the full text of each eligible paper 
was reviewed to identify studies that met the inclusion cri-
teria. In addition, if studies included both adult and pediat-
ric participants, the instruments applied were listed in our 
results (i.e., the number of instruments may be greater than 
the number of publications, and some pediatric-specific 
instruments are shown in the results).
PubMed, Embase, Web of Science search (n=1 ) Last search: 2012679 May 8
Search strategy:
(('organ  ransplantation' OR 'liver transplant*' OR 'hepatic transplant*' OR 'heart
transplant*' OR 'cardiac transplant*' OR 'lung transplant*' OR 'pulmonary transplant*'
OR 'organ transplant*' OR 'pancreatic transplant*' OR 'pancreas transplant*' OR
'kidney transplant*' OR 'renal transplant*') AND ('quality of life' OR 'QoL' OR 'HRQoL'
OR 'functional status' OR 'complaint*' OR 'physical functioning' OR 'well-being' OR
'wellbeing' OR 'patient reported outcome*' OR 'health survey*' OR 'health
questionnair*' OR 'health instrument*') NOT ('review' [Publication Type] OR ('infant'
OR 'child' OR 'adolescent')) AND ('English' [language]))
t
Records remained titlefor and
abstract 8013screening (n= )
Records remained for full text
analysis (n=1 )370
Studies included from the
literature review (n= )1218
1- Duplicated studies (n=4 )666
Exclusions (n= )4666
4- 421Study only on children (n= )
Exclusions (n= )6643
1- No HRQoL evaluation (n= )3611
9- Duplicated studies (n=12)
10 6- No English study (n= )
6- 266Study only on candidates (n= )
3 or review- No original study
(n= )448
5- 317Study only on donors (n= )
8- No human study (n=24)
2- No related Tx study or other organ
Tx studies (n= )1469
7- No abstract / full text available
(n=69)
Methodology review for
extracting all HRQoL instruments







2- No full text available (n=51)
1- Not mentioned the name of
HRQoL instrument (n=81)
3- No original study or review (n=10)
4- No HRQoL evaluation (n=10)
Exclusions (n= )152
Fig. 1  Studies inclusion process. HRQoL health-related quality of life, Tx transplant
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2.3  Health Items Extraction
We checked the names of the extracted instruments in the 
different studies to identify the standard unique name for 
each instrument. In the next step, the names and the items 
of the extracted instruments were reviewed. Thus, for each 
instrument, we identified the intended type and dimensions 
of HRQoL that were assessed (e.g., general health, disease 
burden, social aspects, etc.). Based on the concepts under-
pinning the items, we then divided the instruments into 
four groups: generic (overall) HRQoL; domain-specific 
HRQoL; disease-/organ-specific HRQoL; and transplant-
specific HRQoL.
The transplant-specific HRQoL instruments were 
reviewed by two authors (AS and KV) and health items 
were extracted. In this stage, all items were listed regard-
less of whether they belonged to the concept of HRQoL. 
If a health item occurred in multiple instruments, the most 
frequent or shortest phrase was selected for the inventory. 
In the meetings with all authors, health items were catego-
rized into three broad domains of health: physical, psy-
chological, and social. Items that were clearly irrelevant 
to the measurement of HRQoL (e.g., religion or income 
level) were eliminated.
The main aim of this study is to provide an informative 
pool of items for the development of a new HRQoL instru-
ment. To display the items in a clear and organized way, 
a technique called HealthFan© was used [24]. All health 
items included were arranged in a diagram and were classi-
fied under three higher order major domains (physical, men-
tal, and social) to create a clear and concise overview. The 
sub-domains were graphically presented under each major 
domain, thereby listing the health items in a systematic way.
3  Results
Based on the search strategy, we identified 4381 articles in 
PubMed, 5066 in Embase, and 3232 in Web of Science, of 
which 1218 met the inclusion criteria (Fig. 1). There were 
120 related titles (most published before 2000) for which we 
did not find the full text and therefore were unable to extract 
data from them. Furthermore, the names of the HRQoL 
instruments applied were not mentioned in 81 articles. The 
majority of the publications assessed kidney recipients (525 
articles), followed by liver (340 articles), heart (196 arti-
cles), lung (131 articles), and pancreas (20 articles) recipi-
ents. We also included 138 articles that consisted of two or 
more different groups of solid organ recipients. We identified 
418 distinct instruments that were divided into four groups: 
generic HRQoL; domain-specific HRQoL; disease-/organ-
specific HRQoL; and transplant-specific HRQoL.
3.1  Instruments and Outcome Measures
3.1.1  Generic (Overall) HRQoL Instruments
Generic instruments assess global aspects of health status 
and are thus potentially suitable for a wide range of patient 
groups. This literature review found that the majority of 
solid organ transplantation studies applied generic HRQoL 
instruments. The SF-36 was by far the most frequently used 
generic instrument in post-transplant HRQoL studies, fol-
lowed by the Karnofsky Performance Status Scale (KPS), 
and the Sickness Impact Profile (SIP) (Table 1). The com-
plete list of generic HRQoL instruments is available in 
Appendix 1 in the electronic supplementary material (ESM).
3.1.2  Domain‑Specific HRQoL Instruments
Domain-specific instruments measure one particular aspect 
of health, such as life satisfaction or social functioning. 
Contrary to generic or organ-specific instruments that 
cover broad aspects of health, these instruments assess a 
particular dimension of health in detail. Instruments that 
assess depressive and/or anxiety symptoms were the most 
frequently applied domain-specific HRQoL instruments 
in transplantation studies. Moreover, because insomnia is 
one of the most frequently reported side effects of immu-
nosuppressive medications [42], sleep quality assessment 
was frequent in our findings. Social support and life satis-
faction instruments were the third most frequently applied 
domain-specific HRQoL instruments in transplantation stud-
ies (Table 1). The complete list of domain-specific HRQoL 
instruments is available in Appendix 2 in the ESM.
3.1.3  Disease‑/Organ‑Specific HRQoL Instruments
These instruments are designed to measure the patient’s per-
ceptions of a specific health problem in a particular organ 
or disease (e.g., respiratory symptoms, gastrointestinal 
symptoms, heart failure, etc.). The Kidney Disease Quality 
of Life Short Form (KDQOL-SF) is the most commonly 
applied organ-specific HRQoL instrument in solid organ 
transplant patients. Table 2 introduces the characteristics of 
the most frequently applied kidney-, liver-, lung-, pancreas-, 
and heart-targeted HRQoL instruments. The complete list of 
disease-/organ-specific HRQoL instruments is available in 
Appendix 3 in the ESM.
3.1.4  Transplant‑Specific HRQoL Instruments
Transplant-specific instruments were developed to evaluate 
certain aspects of the health status of patients who receive a 
graft, such as physical symptoms or medication side effects. 
Many of these tools are modified modules of disease-specific 
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instruments that contain items pertaining to the transplanta-
tion setting and can be used for recipients of a particular kind 
of organ. A few instruments were designed for transplants of 
any type and have been used in studies that include various 
transplanted organs. Table 2 briefly describes the charac-
teristics of the most frequently applied transplant-specific 
HRQoL instruments. The complete list of transplant-specific 
HRQoL instruments is available in Appendix 4 in the ESM.
3.2  Health Items
To obtain an overview of the health domains that are cur-
rently assessed by transplant-specific instruments, an inven-
tory was made of the health items in these instruments. In 
total, 576 items were extracted (full list available on request 
from the author). After elimination of the irrelevant items 
and merging repetitions and items that assessed similar con-
cepts, 78 distinct health items remained for development by 
our HealthFan tool. Items that assessed physical symptoms 
were commonly repeated in different transplant-specific 
instruments (Fig. 2).
These 78 health items were classified into three broad 
domains (colored areas): physical, mental, and social 
(Fig. 3). To provide a visual overview, health items were 
subdivided into 16 sub-domains (filled-in dots). The class of 
physical items was subdivided into belly, body heat, chest, 
eating, energy, pain, physical, respiratory, senses, and skin. 
The class of mental items was subdivided into cognition, 
feelings, and worries. The class of social items was subdi-
vided into activities, autonomy, and relationships.
4  Discussion
Ever since the concept of HRQoL was introduced, it has 
been a challenge to define and measure it [58]. No single 
instrument can be construed as the gold standard for meas-
uring HRQoL in different populations, particularly when 
they are heterogeneous. One of the aims of this paper was 
Table 1  Characteristics of the top three prominent administered generic and domain-specific health-related quality-of-life instruments
Instrument name Instrument type Items (N) Domains Year Frequency











Karnofsky Performance Status Scale 
(KPS) [40]
Generic 11 Performance status 1948 78
Sickness Impact Profile (SIP) [41] Generic 136 Physical items (ambulation, mobility, 
and body care/movement)
Psychosocial items (social interaction; 
communication; alertness behavior; 
emotional behavior; home manage-
ment; eating; sleep/rest; recreation 
and pastimes; and work)
1981 75
Hospital Anxiety and Depression 
Scale (HADS) [43]





Pittsburgh Sleep Quality Index (PSQI) 
[44]





Use of sleep medication
Daytime dysfunction
1988 26
Social Support Questionnaire 
(F-SozU) [45]




Satisfaction with the received support
1989 13
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Table 2  Characteristics of the top five prominent administered organ- and transplant-specific HRQoL instruments
Instrument name Instrument type Items (N) Domains Year Frequency
Organ-specific instruments
 Kidney Disease Quality of Life Short 
Form (KDQOL-SF) [46]
Kidney-targeted 79 8 SF-36 domains
Symptoms/problems
Effects of kidney disease
Burden of kidney disease
Work status
Cognitive function







 Liver Disease Quality of Life instrument 
(LDQOL) [47]
Liver-targeted 111 8 SF-36 domains
Symptoms of liver disease








Quality of social interaction
Health distress
Stigma of liver disease
2000 18
 St. George’s Respiratory Questionnaire 
(SGRQ) [48]
Lung-targeted 50 Symptom (illness status such as cough, 
sputum production, and dyspnea)
Activity (activities that cause breathlessness 
and activities limited by breathlessness)
Impact (social functioning and psychologi-
cal disturbances resulting from airways 
disease)
1991 17
 Diabetes Quality of Life questionnaire 
(DQOL) [49]
Pancreas-targeted 62 Core items (satisfaction, impact, diabetes 
worry, and social/vocational worry)
Auxiliary questions about adolescent 
patients (schooling experience and family 
relationships)
1988 14
 Minnesota Living with Heart Failure 
Questionnaire (MLHFQ) [50]




 End-Stage Renal Disease Symptom 
Checklist-Transplantation Module 
(ESRD-SCLTM) [51]




Cardiac and renal dysfunction
Side effects of corticosteroids
Increased growth of gum and hair
1999 20
 Kidney Transplant Questionnaire (KTQ) 
[52]






 Modified Transplant Symptom Occur-
rence and Symptom Distress Scale 
(MTSOSD)
[53, 54]
All organs tx-targeted 59 Symptom occurrence (cognitive compo-
nent) exclusively related to the side effects 
of the immunosuppressant
Symptom distress (emotional component) 
exclusively related to the side effects of 
the immunosuppressant
1985 17
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to identify all HRQoL instruments that have been applied 
thus far among solid organ transplant patients. On the basis 
of this review, we compiled a complete list of all HRQoL 
instruments that have been developed or applied to date in 
the field of solid organ transplantation as well as a compre-
hensive list of health items. We discovered that different 
studies sometimes refer to a particular instrument by differ-
ent names. We carefully selected the most generally known 
name corresponding to each instrument. Additionally, we 
developed a helpful scheme to depict relevant health items.
This review revealed that the majority of publications did 
not provide a logical rationale for the choice of the HRQoL 
instrument. Additionally, 81 publications did not mention 
the name or the reference for the HRQoL instruments that 
were applied. Moreover, the validity of some of the HRQoL 
instruments seems questionable, as the studies did not cite 
a source that described the development and validation 
procedure. The overview of instruments that we present in 
this study will be useful in the process of instrument selec-
tion in future studies and is conducive to credible findings.
The health assessment instruments most commonly 
reported in the literature were generic measures, and 
among these the SF-36 was particularly frequent. These 
generic instruments have a rich history of assessing psy-
chometric properties and performing validation studies in 
general populations and many patient groups. Their wide 
application also enables researchers to compare results from 
transplant patients with those from the general population. 
However, these instruments were not developed specifically 
for transplant patients. Consequently, they do not capture 
the most salient health domains of organ recipients. Using 
generic instruments alongside transplant-specific instru-
ments would make the results more comparable. Together 
they could detect the unanticipated positive or negative 
Table 2  (continued)
Instrument name Instrument type Items (N) Domains Year Frequency
 Transplant Effects Questionnaire (TxEQ)
[55, 56]














Fig. 2  Frequency of health 




















Frequency of health items
178 A. Shahabeddin Parizi et al.
effects of transplantation that are not covered by specific 
instruments. However, relying solely on generic instruments 
may be insufficient to discover clinically relevant changes in 
post-transplant patients [59].
Domain-specific instruments, especially those measuring 
psychological symptoms, were the second most commonly 
used instruments. The literature has emphasized the impor-
tance of assessing psychological issues, due to their high 
prevalence and their enormous impact on the health status 
of transplant patients [60–63]. Moreover, as found in this 
review, the items of some very frequently used transplant-
specific HRQoL instruments (e.g., Transplant Effects Ques-
tionnaire (TxEQ), Heart Transplant Symptom Checklist, and 
Heart Transplant Stressor Scale) are restricted to the psy-
chological domain of HRQoL. Although domain-specific 
instruments provide detailed data on their target domain, 
they do not give a global sum score that can be interpreted 
for all domains of HRQoL. We expect that the list of selected 
health items of domain-specific instruments in the HRQoL 
studies of post-transplant patients will be very informative.
Disease- or organ-specific HRQoL instruments were 
the third most frequently applied instruments in studies in 
transplant patients. These include items that focus on a par-
ticular disease or organ. Therefore, in theory, they provide 
more accurate estimates of HRQoL, with higher consist-
ency and reliability for their target population (i.e., recipients 
of a specific type of organ). However, the content of these 
instruments also has certain shortfalls. For example, all of 
the instruments that we described in the results section were 





















































































Do things for yourself
Physical independence
D cyependen others
Control over your life
Autonomy
T ingalk about transplantation














Fig. 3  Selected extracted health items organized into physical, mental, and social domains (HealthFan)
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disease of that organ (i.e., before transplantation) and were 
therefore not, or less, applicable after transplantation. Addi-
tionally, it is difficult to interpret the results of organ-specific 
instruments in heterogeneous patient groups who received 
different organs. We suggest that the application of organ-
specific instruments should be limited to the transplant can-
didates, since the health issues are usually substantially dif-
ferent after transplantation [3, 15, 64, 65].
Our review revealed that, despite the availability of trans-
plant-specific instruments, only a few studies have applied 
these types of instruments to measure HRQoL. This low 
level of application, which has also been observed in some 
previous reviews [3, 4, 18–20, 66–70], might be explained in 
several ways. First, transplant-specific instruments are rela-
tively new, meaning that many longitudinal studies started 
data collection before transplant-specific instruments were 
available. Second, by applying generic or domain-specific 
instruments, researchers can compare their results with char-
acteristics of various other populations, whereas transplant-
specific instruments restrict the comparability across studies. 
Third, most transplant-specific instruments (e.g., End-Stage 
Renal Disease Symptom Checklist-Transplantation Module 
(ESRD-SCLTM), which includes 43 items, or the Modi-
fied Transplant Symptom Occurrence and Symptom Dis-
tress Scale (MTSOSD), which includes 59 items) comprise 
more items than most generic instruments (e.g., EQ-5D, 
which includes five items, or the SF-36, which includes 36 
items), which makes them lengthy and thus less desirable 
for clinical studies, especially those that require repeated 
measurements.
We consider that the current transplant-specific instru-
ments have more potential than generic HRQoL instruments 
for use in post-transplant research. However, given that the 
content of the available instruments is largely determined by 
experts rather than patients, it is currently unclear whether 
the health items included in these instruments are relevant 
from the perspective of the patients. In addition, the cur-
rent instruments are not preference-based, meaning the 
health items are not weighted to generate a single value that 
expresses the overall quality of the patient’s health condi-
tion. This makes the results more complicated to interpret 
and also not suitable for use in cost-utility studies to support 
decision makers. Therefore, it might be necessary to develop 
one, or even a set of, targeted HRQoL measurement instru-
ments for solid organ recipients. The development strategy 
for such a future instrument must take into account the input 
of patients at all steps, including (1) item generation based 
on review of the literature and patient input; (2) item selec-
tion; (3) value judgment on the items. Given the increasing 
use of smartphones and touchscreens, new HRQoL instru-
ments might be devised as mobile applications, which would 
make them more convenient for patients to use and research-
ers to apply.
This review had a very broad search strategy, which 
ensured we included all articles that evaluated HRQoL 
after solid organ transplantation. We carefully assessed the 
selection of eligible studies and provided the complete list 
of HRQoL instruments in our results. The HealthFan listed 
the health items in a systematic way. In our next study, this 
graphical arrangement of the health items available will 
be used to present the items to post-transplant patients to 
select or add items they consider most important. We believe 
that, in this way, patients will have a prominent role in the 
process of developing a generic transplant health-outcome 
instrument.
Our review has some limitations, which should be men-
tioned. The inclusion of only English-language publica-
tions might limit the results to those instruments that have 
appeared in an English version. However, we did include 
non-English instruments if they were published in an Eng-
lish-language article. Another possible limitation is the 
exclusion of studies that had only assessed pre-transplant 
or pediatric patients. However, for our purposes, these 
two groups are not comparable with adult post-transplant 
patients. Post-transplant issues (e.g., immunosuppressive 
side effects) do not pertain to pre-transplant patients, while 
adult issues (e.g., partner relationships and employability) 
cannot be compared with childhood issues.
5  Conclusion
We emphasize the need to develop a preference-based, 
transplant-specific HRQoL instrument that is easy to apply 
and that targets the health issues of solid organ recipients. 
The current set of key health items that was collected in this 
study is a valuable outcome that will be used in the next 
developmental phase. In the following step, patients’ opin-
ions will be included through focus group meetings, and an 
online survey will be carried out to derive the content for a 
new patient-centered, transplant-specific instrument.
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